{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:07:04Z","timestamp":1772536024216,"version":"3.50.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-023-07516-2","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T05:00:24Z","timestamp":1698901224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Contemporary Medical Management of Peripheral Arterial Disease"],"prefix":"10.1007","author":[{"given":"Ian O.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-4414","authenticated-orcid":false,"given":"Jayer","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"8","key":"7516_CR1","doi-asserted-by":"publisher","first-page":"E1020","DOI":"10.1016\/S2214-109x(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):E1020\u2013E30. https:\/\/doi.org\/10.1016\/S2214-109x(19)30255-4","journal-title":"Lancet Glob Health"},{"issue":"4","key":"7516_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/J.Amepre.2006.12.010","volume":"32","author":"MA Allison","year":"2007","unstructured":"Allison MA, Ho E, Denenberg JO, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328\u201333. https:\/\/doi.org\/10.1016\/J.Amepre.2006.12.010","journal-title":"Am J Prev Med"},{"issue":"9","key":"7516_CR3","doi-asserted-by":"publisher","first-page":"E171","DOI":"10.1161\/Cir.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):E171\u2013E91. https:\/\/doi.org\/10.1161\/Cir.0000000000001005","journal-title":"Circulation."},{"issue":"6","key":"7516_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.Cir.0000137913.26087.F0","volume":"110","author":"E Selvin","year":"2004","unstructured":"Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health And Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738\u201343. https:\/\/doi.org\/10.1161\/01.Cir.0000137913.26087.F0","journal-title":"Circulation."},{"issue":"2","key":"7516_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/01.Atv.18.2.185","volume":"18","author":"WT Meijer","year":"1998","unstructured":"Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18(2):185\u201392. https:\/\/doi.org\/10.1161\/01.Atv.18.2.185","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"7516_CR6","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1161\/Circulationaha.105.546507","volume":"112","author":"MH Criqui","year":"2005","unstructured":"Criqui MH, Vargas V, Denenberg JO, et al. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112(17):2703\u20137. https:\/\/doi.org\/10.1161\/Circulationaha.105.546507","journal-title":"Circulation."},{"issue":"1","key":"7516_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.Jvs.2006.09.044","volume":"45","author":"MH Eslami","year":"2007","unstructured":"Eslami MH, Zayaruzny M, Fitzgerald GA. The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg. 2007;45(1):55\u20139. https:\/\/doi.org\/10.1016\/J.Jvs.2006.09.044","journal-title":"J Vasc Surg"},{"issue":"11","key":"7516_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/Cir.0b013e31824c39ba","volume":"125","author":"AT Hirsch","year":"2012","unstructured":"Hirsch AT, Allison MA, Gomes AS, et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125(11):1449\u201372. https:\/\/doi.org\/10.1161\/Cir.0b013e31824c39ba","journal-title":"Circulation."},{"issue":"4","key":"7516_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/J.Cjca.2018.01.009","volume":"34","author":"K Srivaratharajah","year":"2018","unstructured":"Srivaratharajah K, Abramson BL. Women and peripheral arterial disease: a review of sex differences in epidemiology, clinical manifestations, and outcomes. Can J Cardiol. 2018;34(4):356\u201361. https:\/\/doi.org\/10.1016\/J.Cjca.2018.01.009","journal-title":"Can J Cardiol"},{"key":"7516_CR10","doi-asserted-by":"publisher","unstructured":"Vart P, Coresh J, Kwak L, et al. Socioeconomic status and incidence of hospitalization with lower-extremity peripheral artery disease: atherosclerosis risk in communities study. J Am Heart Assoc. 2017;6(8) https:\/\/doi.org\/10.1161\/Jaha.116.004995","DOI":"10.1161\/Jaha.116.004995"},{"issue":"4","key":"7516_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/Circoutcomes.113.000618","volume":"7","author":"RL Pande","year":"2014","unstructured":"Pande RL, Creager MA. Socioeconomic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes. 2014;7(4):532\u20139. https:\/\/doi.org\/10.1161\/Circoutcomes.113.000618","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3 Suppl","key":"7516_CR12","doi-asserted-by":"publisher","first-page":"2s","DOI":"10.1016\/J.Jvs.2014.12.009","volume":"61","author":"MS Conte","year":"2015","unstructured":"Society For Vascular Surgery Lower Extremity Guidelines Writing G, Conte MS, Pomposelli FB, et al. Society For Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61(3 Suppl):2s\u201341s. https:\/\/doi.org\/10.1016\/J.Jvs.2014.12.009","journal-title":"J Vasc Surg"},{"issue":"3 Suppl","key":"7516_CR13","doi-asserted-by":"publisher","first-page":"42s","DOI":"10.1016\/J.Jvs.2014.12.008","volume":"61","author":"F Alahdab","year":"2015","unstructured":"Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3 Suppl):42s\u201353s. https:\/\/doi.org\/10.1016\/J.Jvs.2014.12.008","journal-title":"J Vasc Surg"},{"issue":"7","key":"7516_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/S41569-021-00663-9","volume":"19","author":"J Golledge","year":"2022","unstructured":"Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456\u201374. https:\/\/doi.org\/10.1038\/S41569-021-00663-9","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"7516_CR15","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1161\/Circresaha.121.318258","volume":"128","author":"MP Bonaca","year":"2021","unstructured":"Bonaca MP, Hamburg NM, Creager MA. Contemporary medical management of peripheral artery disease. Circ Res. 2021;128(12):1868\u201384. https:\/\/doi.org\/10.1161\/Circresaha.121.318258","journal-title":"Circ Res"},{"issue":"4","key":"7516_CR16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/J.Jvs.2020.08.129","volume":"73","author":"DR Nastasi","year":"2021","unstructured":"Nastasi DR, Moxon JV, Norman R, et al. The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease. J Vasc Surg. 2021;73(4):1396\u2013403. https:\/\/doi.org\/10.1016\/J.Jvs.2020.08.129","journal-title":"J Vasc Surg"},{"issue":"12","key":"7516_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/J.Jacc.2008.09.063","volume":"53","author":"MM Mcdermott","year":"2009","unstructured":"Mcdermott MM, Guralnik JM, Tian L, et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking And Leg Circulation Study). J Am Coll Cardiol. 2009;53(12):1056\u201362. https:\/\/doi.org\/10.1016\/J.Jacc.2008.09.063","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"7516_CR18","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/J.Jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731\u20137. https:\/\/doi.org\/10.1016\/J.Jacc.2003.12.047","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"7516_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/Nrcardio.2013.8","volume":"10","author":"A Csordas","year":"2013","unstructured":"Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10(4):219\u201330. https:\/\/doi.org\/10.1038\/Nrcardio.2013.8","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"7516_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0003319711420131","volume":"63","author":"M Yarlioglues","year":"2012","unstructured":"Yarlioglues M, Ardic I, Dogdu O, et al. The acute effects of passive smoking on mean platelet volume in healthy volunteers. Angiology. 2012;63(5):353\u20137. https:\/\/doi.org\/10.1177\/0003319711420131","journal-title":"Angiology."},{"issue":"5","key":"7516_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/S00011-011-0308-7","volume":"60","author":"RB Goncalves","year":"2011","unstructured":"Goncalves RB, Coletta RD, Silverio KG, et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res. 2011;60(5):409\u201324. https:\/\/doi.org\/10.1007\/S00011-011-0308-7","journal-title":"Inflamm Res"},{"issue":"7","key":"7516_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jama.1972.03200200011003","volume":"221","author":"T Gordon","year":"1972","unstructured":"Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham Study. Jama. 1972;221(7):661\u20136.","journal-title":"Jama."},{"issue":"2","key":"7516_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/Hrt.72.2.128","volume":"72","author":"D Bainton","year":"1994","unstructured":"Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J. 1994;72(2):128\u201332. https:\/\/doi.org\/10.1136\/Hrt.72.2.128","journal-title":"Br Heart J"},{"issue":"11-12","key":"7516_CR24","first-page":"635","volume":"154","author":"R Lassila","year":"1988","unstructured":"Lassila R, Lepantalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand. 1988;154(11-12):635\u201340.","journal-title":"Acta Chir Scand"},{"issue":"12","key":"7516_CR25","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1161\/Cir.0000000000000470","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College Of Cardiology\/American Heart Association Task Force On Clinical Practice Guidelines. Circulation. 2017;135(12):E686\u2013725. https:\/\/doi.org\/10.1161\/Cir.0000000000000470","journal-title":"Circulation."},{"issue":"2","key":"7516_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/J.Semvascsurg.2015.10.001","volume":"28","author":"EL Spangler","year":"2015","unstructured":"Spangler EL, Goodney PP. Smoking cessation strategies in vascular surgery. Semin Vasc Surg. 2015;28(2):80\u20135. https:\/\/doi.org\/10.1053\/J.Semvascsurg.2015.10.001","journal-title":"Semin Vasc Surg"},{"issue":"5","key":"7516_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/Jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014;311(5):507\u201320. https:\/\/doi.org\/10.1001\/Jama.2013.284427","journal-title":"Jama."},{"issue":"17","key":"7516_CR28","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1161\/Cir.0000000000000596","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College Of Cardiology\/American Heart Association Task Force On Clinical Practice Guidelines. Circulation. 2018;138(17):E484\u2013594. https:\/\/doi.org\/10.1161\/Cir.0000000000000596","journal-title":"Circulation."},{"issue":"5","key":"7516_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/01.Cir.0000049640.46039.52","volume":"107","author":"PS Mehler","year":"2003","unstructured":"Mehler PS, Coll JR, Estacio R, et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(5):753\u20136. https:\/\/doi.org\/10.1161\/01.Cir.0000049640.46039.52","journal-title":"Circulation."},{"issue":"12","key":"7516_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/S00392-010-0184-0","volume":"99","author":"AR Zankl","year":"2010","unstructured":"Zankl AR, Ivandic B, Andrassy M, et al. Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease. Clin Res Cardiol. 2010;99(12):787\u201394. https:\/\/doi.org\/10.1007\/S00392-010-0184-0","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"7516_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.Ehj.2003.10.033","volume":"25","author":"J Ostergren","year":"2004","unstructured":"Ostergren J, Sleight P, Dagenais G, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25(1):17\u201324. https:\/\/doi.org\/10.1016\/J.Ehj.2003.10.033","journal-title":"Eur Heart J"},{"issue":"22","key":"7516_CR32","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/Nejmoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Group Sr, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316. https:\/\/doi.org\/10.1056\/Nejmoa1511939","journal-title":"N Engl J Med"},{"issue":"32","key":"7516_CR33","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/Eurheartj\/Ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, et al. Low-Density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372. https:\/\/doi.org\/10.1093\/Eurheartj\/Ehx144","journal-title":"Eur Heart J"},{"issue":"2","key":"7516_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.Cir.0000133317.49796.0e","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110(2):227\u201339. https:\/\/doi.org\/10.1161\/01.Cir.0000133317.49796.0e","journal-title":"Circulation."},{"issue":"25","key":"7516_CR35","doi-asserted-by":"publisher","first-page":"E1082","DOI":"10.1161\/Cir.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College Of Cardiology\/American Heart Association Task Force On Clinical Practice Guidelines. Circulation. 2019;139(25):E1082\u2013E143. https:\/\/doi.org\/10.1161\/Cir.0000000000000625","journal-title":"Circulation."},{"issue":"2","key":"7516_CR36","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1161\/Atv.0000000000000073","volume":"39","author":"CB Newman","year":"2019","unstructured":"Newman CB, Preiss D, Tobert JA, et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2019;39(2):E38\u201381. https:\/\/doi.org\/10.1161\/Atv.0000000000000073","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"7516_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/J.Jhep.2011.07.023","volume":"56","author":"E Bjornsson","year":"2012","unstructured":"Bjornsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol. 2012;56(2):374\u201380. https:\/\/doi.org\/10.1016\/J.Jhep.2011.07.023","journal-title":"J Hepatol"},{"issue":"4","key":"7516_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/Circulationaha.117.032235","volume":"137","author":"MP Bonaca","year":"2018","unstructured":"Bonaca MP, Nault P, Giugliano RP, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition In Subjects With Elevated Risk). Circulation. 2018;137(4):338\u201350. https:\/\/doi.org\/10.1161\/Circulationaha.117.032235","journal-title":"Circulation."},{"issue":"9","key":"7516_CR39","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/J.Jacc.2019.03.013","volume":"74","author":"JW Jukema","year":"2019","unstructured":"Jukema JW, Szarek M, Zijlstra LE, et al. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial. J Am Coll Cardiol. 2019;74(9):1167\u201376. https:\/\/doi.org\/10.1016\/J.Jacc.2019.03.013","journal-title":"J Am Coll Cardiol"},{"issue":"7241","key":"7516_CR40","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/Bmj.320.7241.1062","volume":"320","author":"R Donnelly","year":"2000","unstructured":"Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. ABC of arterial and venous disease: vascular complications of diabetes. Bmj. 2000;320(7241):1062\u20136. https:\/\/doi.org\/10.1136\/Bmj.320.7241.1062","journal-title":"Bmj."},{"issue":"2 Suppl","key":"7516_CR41","doi-asserted-by":"publisher","first-page":"3s","DOI":"10.1016\/J.Jvs.2015.10.003","volume":"63","author":"A Hingorani","year":"2016","unstructured":"Hingorani A, Lamuraglia GM, Henke P, et al. The management of diabetic foot: a clinical practice guideline by the Society For Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society For Vascular Medicine. J Vasc Surg. 2016;63(2 Suppl):3s\u201321s. https:\/\/doi.org\/10.1016\/J.Jvs.2015.10.003","journal-title":"J Vasc Surg"},{"issue":"8","key":"7516_CR42","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2337\/Diacare.24.8.1433","volume":"24","author":"EB Jude","year":"2001","unstructured":"Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433\u20137. https:\/\/doi.org\/10.2337\/Diacare.24.8.1433","journal-title":"Diabetes Care"},{"issue":"12","key":"7516_CR43","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2337\/Diacare.26.12.3333","volume":"26","author":"American Diabetes A","year":"2003","unstructured":"American Diabetes A. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333\u201341. https:\/\/doi.org\/10.2337\/Diacare.26.12.3333","journal-title":"Diabetes Care"},{"issue":"7","key":"7516_CR44","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2337\/Diacare.27.7.1668","volume":"27","author":"CH Van Schie","year":"2004","unstructured":"Van Schie CH, Vermigli C, Carrington AL, Boulton A. Muscle weakness and foot deformities in diabetes: relationship to neuropathy and foot ulceration in caucasian diabetic men. Diabetes Care. 2004;27(7):1668\u201373. https:\/\/doi.org\/10.2337\/Diacare.27.7.1668","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"7516_CR45","doi-asserted-by":"publisher","first-page":"E3266","DOI":"10.1002\/Dmrr.3266","volume":"36","author":"NC Schaper","year":"2020","unstructured":"Schaper NC, Van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):E3266. https:\/\/doi.org\/10.1002\/Dmrr.3266","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"7516_CR46","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.2337\/Dc20-S009","volume":"43","author":"American Diabetes A","year":"2020","unstructured":"American Diabetes A. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98\u2013S110. https:\/\/doi.org\/10.2337\/Dc20-S009","journal-title":"Diabetes Care"},{"issue":"1","key":"7516_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/S12933-019-0900-7","volume":"18","author":"Y Han","year":"2019","unstructured":"Han Y, Xie H, Liu Y, et al. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis. Cardiovasc Diabetol. 2019;18(1):96. https:\/\/doi.org\/10.1186\/S12933-019-0900-7","journal-title":"Cardiovasc Diabetol"},{"issue":"10296","key":"7516_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","volume":"398","author":"E Brown","year":"2021","unstructured":"Brown E, HJL H, Cuthbertson DJ, JPH W. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021;398(10296):262\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(21)00536-5","journal-title":"Lancet."},{"issue":"1","key":"7516_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1358863x221143811","volume":"28","author":"N Skeik","year":"2023","unstructured":"Skeik N, Elejla SA, Sethi A, Manunga J, Mirza A. Effects of SGLT2 inhibitors and GLP1-receptor agonists on cardiovascular and limb events in peripheral artery disease: a review. Vasc Med. 2023;28(1):62\u201376. https:\/\/doi.org\/10.1177\/1358863x221143811","journal-title":"Vasc Med"},{"issue":"Suppl 1","key":"7516_CR50","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.2337\/Dc22-S009","volume":"45","author":"American Diabetes Association Professional Practice C","year":"2022","unstructured":"American Diabetes Association Professional Practice C. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S125\u2013S43. https:\/\/doi.org\/10.2337\/Dc22-S009","journal-title":"Diabetes Care"},{"issue":"10","key":"7516_CR51","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.2337\/Dc12-2265","volume":"36","author":"AD Althouse","year":"2013","unstructured":"Althouse AD, Abbott JD, Sutton-Tyrrell K, et al. Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 diabetes (BARI 2D) trial. Diabetes Care. 2013;36(10):3269\u201375. https:\/\/doi.org\/10.2337\/Dc12-2265","journal-title":"Diabetes Care"},{"issue":"3","key":"7516_CR52","first-page":"200","volume":"20","author":"M Haltmayer","year":"2001","unstructured":"Haltmayer M, Mueller T, Horvath W, et al. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001;20(3):200\u20137.","journal-title":"Int Angiol"},{"issue":"5","key":"7516_CR53","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1046\/J.1464-5491.2002.00642.X","volume":"19","author":"C Van Der Feen","year":"2002","unstructured":"Van Der Feen C, Neijens FS, Kanters SD, et al. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med. 2002;19(5):366\u201370. https:\/\/doi.org\/10.1046\/J.1464-5491.2002.00642.X","journal-title":"Diabet Med"},{"key":"7516_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/J.Avsg.2016.11.003","volume":"40","author":"J Chung","year":"2017","unstructured":"Chung J, Modrall JG, Knowles M, et al. Arteriographic patterns of atherosclerosis and the association between diabetes mellitus and ethnicity in chronic critical limb ischemia. Ann Vasc Surg. 2017;40:198\u2013205. https:\/\/doi.org\/10.1016\/J.Avsg.2016.11.003","journal-title":"Ann Vasc Surg"},{"issue":"5","key":"7516_CR55","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/J.Jvs.2007.11.055","volume":"47","author":"CA Rueda","year":"2008","unstructured":"Rueda CA, Nehler MR, Perry DJ, et al. Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design. J Vasc Surg. 2008;47(5):995\u20139. https:\/\/doi.org\/10.1016\/J.Jvs.2007.11.055","journal-title":"J Vasc Surg"},{"issue":"4","key":"7516_CR56","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/J.Jvs.2018.12.054","volume":"70","author":"B Ramanan","year":"2019","unstructured":"Ramanan B, Jeon-Slaughter H, Chen X, Modrall JG, Tsai S. Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis. J Vasc Surg. 2019;70(4):1217\u201324. https:\/\/doi.org\/10.1016\/J.Jvs.2018.12.054","journal-title":"J Vasc Surg"},{"issue":"6","key":"7516_CR57","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1067\/Mva.2001.119749","volume":"34","author":"R Aquino","year":"2001","unstructured":"Aquino R, Johnnides C, Makaroun M, et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg. 2001;34(6):962\u201370. https:\/\/doi.org\/10.1067\/Mva.2001.119749","journal-title":"J Vasc Surg"},{"issue":"2","key":"7516_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1067\/Mva.2001.112210","volume":"33","author":"SC Muluk","year":"2001","unstructured":"Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg. 2001;33(2):251\u20137. https:\/\/doi.org\/10.1067\/Mva.2001.112210","journal-title":"J Vasc Surg"},{"issue":"12","key":"7516_CR59","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jama.1995.03530120067043","volume":"274","author":"AW Gardner","year":"1995","unstructured":"Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. Jama. 1995;274(12):975\u201380.","journal-title":"Jama"},{"issue":"12","key":"7516_CR60","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1046\/J.1532-5415.2002.50604.X","volume":"50","author":"JG Regensteiner","year":"2002","unstructured":"Regensteiner JG, Ware JE Jr, Mccarthy WJ, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002;50(12):1939\u201346. https:\/\/doi.org\/10.1046\/J.1532-5415.2002.50604.X","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"7516_CR61","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1185\/030079904x4464","volume":"20","author":"AH Barnett","year":"2004","unstructured":"Barnett AH, Bradbury AW, Brittenden J, et al. The role of cilostazol in the treatment of intermittent claudication. Curr Med Res Opin. 2004;20(10):1661\u201370. https:\/\/doi.org\/10.1185\/030079904x4464","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"7516_CR62","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/Eurheartj\/Ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society For Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesendorsed by: the European Stroke Organization (ESO)The task force for the diagnosis and treatment of peripheral arterial diseases of the European Society Of Cardiology (ESC) and of the European Society For Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763\u2013816. https:\/\/doi.org\/10.1093\/Eurheartj\/Ehx095","journal-title":"Eur Heart J."},{"issue":"9038","key":"7516_CR63","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"Committee CS","year":"1996","unstructured":"Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Caprie Steerin Comm Lancet. 1996;348(9038):1329\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(96)09457-3","journal-title":"Caprie Steerin Comm Lancet"},{"issue":"1","key":"7516_CR64","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/Nejmoa1611688","volume":"376","author":"WR Hiatt","year":"2017","unstructured":"Hiatt WR, Fowkes FG, Heizer G, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2017;376(1):32\u201340. https:\/\/doi.org\/10.1056\/Nejmoa1611688","journal-title":"N Engl J Med"},{"issue":"5","key":"7516_CR65","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/J.Jvs.2017.07.065","volume":"66","author":"M Guirgis","year":"2017","unstructured":"Guirgis M, Thompson P, Jansen S. Review of aspirin and clopidogrel resistance in peripheral arterial disease. J Vasc Surg. 2017;66(5):1576\u201386. https:\/\/doi.org\/10.1016\/J.Jvs.2017.07.065","journal-title":"J Vasc Surg"},{"issue":"20","key":"7516_CR66","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/J.Jacc.2018.03.008","volume":"71","author":"SS Anand","year":"2018","unstructured":"Anand SS, Caron F, Eikelboom JW, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the compass trial. J Am Coll Cardiol. 2018;71(20):2306\u201315. https:\/\/doi.org\/10.1016\/J.Jacc.2018.03.008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"7516_CR67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/J.Jvs.2013.08.003","volume":"59","author":"JL Mills Sr","year":"2014","unstructured":"Mills JL Sr, Conte MS, Armstrong DG, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220\u201334. https:\/\/doi.org\/10.1016\/J.Jvs.2013.08.003","journal-title":"J Vasc Surg"},{"issue":"8","key":"7516_CR68","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/Atvbaha.120.314595","volume":"40","author":"JA Barnes","year":"2020","unstructured":"Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808\u201317. https:\/\/doi.org\/10.1161\/Atvbaha.120.314595","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"7516_CR69","doi-asserted-by":"publisher","first-page":"E3280","DOI":"10.1002\/Dmrr.3280","volume":"36","author":"BA Lipsky","year":"2020","unstructured":"Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):E3280. https:\/\/doi.org\/10.1002\/Dmrr.3280","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"7516_CR70","doi-asserted-by":"publisher","first-page":"E132","DOI":"10.1093\/Cid\/Cis346","volume":"54","author":"BA Lipsky","year":"2012","unstructured":"Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):E132\u201373. https:\/\/doi.org\/10.1093\/Cid\/Cis346","journal-title":"Clin Infect Dis"},{"key":"7516_CR71","first-page":"E10","volume":"16","author":"J Walters","year":"2016","unstructured":"Walters J, Cazzell S, Pham H, Vayser D, Reyzelman A. Healing rates in a multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management and an active comparator in the treatment of full-thickness diabetic foot ulcers. Eplasty. 2016;16:E10.","journal-title":"Eplasty."},{"issue":"1","key":"7516_CR72","first-page":"61","volume":"183","author":"DL Steed","year":"1996","unstructured":"Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg. 1996;183(1):61\u20134.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"7516_CR73","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/J.1524-475x.2009.00485.X","volume":"17","author":"M Cardinal","year":"2009","unstructured":"Cardinal M, Eisenbud DE, Armstrong DG, et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen. 2009;17(3):306\u201311. https:\/\/doi.org\/10.1111\/J.1524-475x.2009.00485.X","journal-title":"Wound Repair Regen"},{"issue":"9","key":"7516_CR74","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/Jamadermatol.2013.4960","volume":"149","author":"JR Wilcox","year":"2013","unstructured":"Wilcox JR, Carter MJ, Covington S. Frequency of debridements and time to heal: a retrospective cohort study of 312 744 wounds. Jama Dermatol. 2013;149(9):1050\u20138. https:\/\/doi.org\/10.1001\/Jamadermatol.2013.4960","journal-title":"Jama Dermatol"},{"issue":"12","key":"7516_CR75","doi-asserted-by":"publisher","first-page":"E203","DOI":"10.2337\/Dc21-1454","volume":"44","author":"VL Nube","year":"2021","unstructured":"Nube VL, White JM, Brewer K, et al. A randomized trial comparing weekly with every second week sharp debridement in people with diabetes-related foot ulcers shows similar healing outcomes: potential benefit to resource utilization. Diabetes Care. 2021;44(12):E203\u2013E5. https:\/\/doi.org\/10.2337\/Dc21-1454","journal-title":"Diabetes Care"},{"issue":"12","key":"7516_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1089\/Wound.2021.0016","volume":"11","author":"D Dayya","year":"2022","unstructured":"Dayya D, O'neill OJ, Huedo-Medina TB, et al. Debridement of diabetic foot ulcers. Adv Wound Care. 2022;11(12):666\u201386. https:\/\/doi.org\/10.1089\/Wound.2021.0016","journal-title":"Adv Wound Care"},{"issue":"3","key":"7516_CR77","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S2213-8587(17)30438-2","volume":"6","author":"M Edmonds","year":"2018","unstructured":"Edmonds M, Lazaro-Martinez JL, Alfayate-Garcia JM, et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018;6(3):186\u201396. https:\/\/doi.org\/10.1016\/S2213-8587(17)30438-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"7516_CR78","doi-asserted-by":"publisher","first-page":"E3283","DOI":"10.1002\/Dmrr.3283","volume":"36","author":"G Rayman","year":"2020","unstructured":"Rayman G, Vas P, Dhatariya K, et al. Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):E3283. https:\/\/doi.org\/10.1002\/Dmrr.3283","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"7516_CR79","first-page":"35","volume":"151","author":"H Ga","year":"1989","unstructured":"Ga H, Jr., Johansen Kh, Barnes Rw, Pierce Ge. Multicenter trial of cadexomer iodine to treat venous stasis ulcer. West J Med. 1989;151(1):35\u20138.","journal-title":"West J Med"},{"issue":"3 Suppl","key":"7516_CR80","doi-asserted-by":"publisher","first-page":"129s","DOI":"10.1097\/Prs.0000000000002645","volume":"138","author":"EL Anghel","year":"2016","unstructured":"Anghel EL, Kim PJ. Negative-pressure wound therapy: a comprehensive review of the evidence. Plast Reconstr Surg. 2016;138(3 Suppl):129s\u201337s. https:\/\/doi.org\/10.1097\/Prs.0000000000002645","journal-title":"Plast Reconstr Surg"},{"issue":"9498","key":"7516_CR81","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/S0140-6736(05)67695-7","volume":"366","author":"DG Armstrong","year":"2005","unstructured":"Armstrong DG, Lavery LA, Diabetic Foot Study C. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(05)67695-7","journal-title":"Lancet."},{"issue":"1s-1","key":"7516_CR82","doi-asserted-by":"publisher","first-page":"16s","DOI":"10.1097\/Prs.0000000000007607","volume":"147","author":"E Faust","year":"2021","unstructured":"Faust E, Opoku-Agyeman JL, Behnam AB. Use of negative-pressure wound therapy with instillation and dwell time: an overview. Plast Reconstr Surg. 2021;147(1s-1):16s\u201326s. https:\/\/doi.org\/10.1097\/Prs.0000000000007607","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"7516_CR83","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S2213-8587(18)30240-7","volume":"6","author":"F Game","year":"2018","unstructured":"Game F, Jeffcoate W, Tarnow L, et al. Leucopatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial. Lancet Diabetes Endocrinol. 2018;6(11):870\u20138. https:\/\/doi.org\/10.1016\/S2213-8587(18)30240-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"7516_CR84","doi-asserted-by":"publisher","first-page":"E1095","DOI":"10.1097\/Gox.0000000000001095","volume":"4","author":"LA Didomenico","year":"2016","unstructured":"Didomenico LA, Orgill DP, Galiano RD, et al. Aseptically processed placental membrane improves healing of diabetic foot ulcerations: prospective, randomized clinical trial. Plast Reconstr Surg Glob Open. 2016;4(10):E1095. https:\/\/doi.org\/10.1097\/Gox.0000000000001095","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"6","key":"7516_CR85","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/Iwj.12395","volume":"12","author":"CM Zelen","year":"2015","unstructured":"Zelen CM, Gould L, Serena TE, et al. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion\/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers. Int Wound J. 2015;12(6):724\u201332. https:\/\/doi.org\/10.1111\/Iwj.12395","journal-title":"Int Wound J"},{"issue":"5","key":"7516_CR86","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/Iwj.12097","volume":"10","author":"CM Zelen","year":"2013","unstructured":"Zelen CM, Serena TE, Denoziere G, Fetterolf DE. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J. 2013;10(5):502\u20137. https:\/\/doi.org\/10.1111\/Iwj.12097","journal-title":"Int Wound J"},{"issue":"2","key":"7516_CR87","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/Iwj.12566","volume":"13","author":"CM Zelen","year":"2016","unstructured":"Zelen CM, Serena TE, Gould L, et al. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost. Int Wound J. 2016;13(2):272\u201382. https:\/\/doi.org\/10.1111\/Iwj.12566","journal-title":"Int Wound J"},{"issue":"5","key":"7516_CR88","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/Iwj.12329","volume":"11","author":"LA Lavery","year":"2014","unstructured":"Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix((R)) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J. 2014;11(5):554\u201360. https:\/\/doi.org\/10.1111\/Iwj.12329","journal-title":"Int Wound J"},{"issue":"7","key":"7516_CR89","first-page":"248","volume":"28","author":"MR Mohajeri-Tehrani","year":"2016","unstructured":"Mohajeri-Tehrani MR, Variji Z, Mohseni S, et al. Comparison of a bioimplant dressing with a wet dressing for the treatment of diabetic foot ulcers: a randomized, controlled clinical trial. Wounds. 2016;28(7):248\u201354.","journal-title":"Wounds."},{"issue":"3","key":"7516_CR90","first-page":"70","volume":"28","author":"RJ Snyder","year":"2016","unstructured":"Snyder RJ, Shimozaki K, Tallis A, et al. A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer. Wounds. 2016;28(3):70\u20137.","journal-title":"Wounds."},{"issue":"3","key":"7516_CR91","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/Wrr.12645","volume":"26","author":"CE Ananian","year":"2018","unstructured":"Ananian CE, Dhillon YS, Van Gils CC, et al. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers. Wound Repair Regen. 2018;26(3):274\u201383. https:\/\/doi.org\/10.1111\/Wrr.12645","journal-title":"Wound Repair Regen"},{"issue":"1","key":"7516_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/Iwj.12976","volume":"16","author":"W Tettelbach","year":"2019","unstructured":"Tettelbach W, Cazzell S, Reyzelman AM, et al. A Confirmatory study on the efficacy of dehydrated human amnion\/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics. Int Wound J. 2019;16(1):19\u201329. https:\/\/doi.org\/10.1111\/Iwj.12976","journal-title":"Int Wound J"},{"issue":"1","key":"7516_CR93","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/Iwj.13001","volume":"16","author":"W Tettelbach","year":"2019","unstructured":"Tettelbach W, Cazzell S, Sigal F, et al. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (Epicord) allograft for the treatment of diabetic foot ulcers. Int Wound J. 2019;16(1):122\u201330. https:\/\/doi.org\/10.1111\/Iwj.13001","journal-title":"Int Wound J"},{"issue":"5","key":"7516_CR94","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/Wrr.12332","volume":"23","author":"RS Kirsner","year":"2015","unstructured":"Kirsner RS, Sabolinski ML, Parsons NB, Skornicki M, Marston WA. Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting. Wound Repair Regen. 2015;23(5):737\u201344. https:\/\/doi.org\/10.1111\/Wrr.12332","journal-title":"Wound Repair Regen"},{"key":"7516_CR95","doi-asserted-by":"publisher","first-page":"88","DOI":"10.22203\/Ecm.V015a07","volume":"15","author":"H Niknejad","year":"2008","unstructured":"Niknejad H, Peirovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88\u201399. https:\/\/doi.org\/10.22203\/Ecm.V015a07","journal-title":"Eur Cell Mater"},{"key":"7516_CR96","doi-asserted-by":"publisher","unstructured":"Driver VR, Lavery LA, Reyzelman AM, et al. A clinical trial of integra template for diabetic foot ulcer treatment wound repair regen. 2015;23(6):891\u2013900. https:\/\/doi.org\/10.1111\/Wrr.12357","DOI":"10.1111\/Wrr.12357"},{"issue":"6","key":"7516_CR97","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/J.Jamcollsurg.2016.02.023","volume":"222","author":"Z Hu","year":"2016","unstructured":"Hu Z, Zhu J, Cao X, et al. Composite skin grafting with human acellular dermal matrix scaffold for treatment of diabetic foot ulcers: a randomized controlled trial. J Am Coll Surg. 2016;222(6):1171\u20139. https:\/\/doi.org\/10.1016\/J.Jamcollsurg.2016.02.023","journal-title":"J Am Coll Surg"},{"issue":"12","key":"7516_CR98","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2337\/Diacare.19.12.1338","volume":"19","author":"E Faglia","year":"1996","unstructured":"Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care. 1996;19(12):1338\u201343. https:\/\/doi.org\/10.2337\/Diacare.19.12.1338","journal-title":"Diabetes Care"},{"issue":"6","key":"7516_CR99","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/Ejvs.2002.1911","volume":"25","author":"A Abidia","year":"2003","unstructured":"Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg. 2003;25(6):513\u20138. https:\/\/doi.org\/10.1053\/Ejvs.2002.1911","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"7516_CR100","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2337\/Dc09-1754","volume":"33","author":"M Londahl","year":"2010","unstructured":"Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998\u20131003. https:\/\/doi.org\/10.2337\/Dc09-1754","journal-title":"Diabetes Care"},{"issue":"3","key":"7516_CR101","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/Dc15-2001","volume":"39","author":"L Fedorko","year":"2016","unstructured":"Fedorko L, Bowen JM, Jones W, et al. Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial. Diabetes Care. 2016;39(3):392\u20139. https:\/\/doi.org\/10.2337\/Dc15-2001","journal-title":"Diabetes Care"},{"issue":"1","key":"7516_CR102","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2337\/Dc17-0654","volume":"41","author":"KTB Santema","year":"2018","unstructured":"Santema KTB, Stoekenbroek RM, Koelemay MJW, et al. Hyperbaric oxygen therapy in the treatment of ischemic lower- extremity ulcers in patients with diabetes: results of the DAMO(2)CLES multicenter randomized clinical trial. Diabetes Care. 2018;41(1):112\u20139. https:\/\/doi.org\/10.2337\/Dc17-0654","journal-title":"Diabetes Care"},{"issue":"11","key":"7516_CR103","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1177\/000313480106701109","volume":"67","author":"RE Grolman","year":"2001","unstructured":"Grolman RE, Wilkerson DK, Taylor J, Allinson P, Zatina MA. Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia. Am Surg. 2001;67(11):1072\u20139.","journal-title":"Am Surg"},{"issue":"4","key":"7516_CR104","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1046\/J.1524-475x.2002.10402.X","volume":"10","author":"CE Fife","year":"2002","unstructured":"Fife CE, Buyukcakir C, Otto GH, et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients. Wound Repair Regen. 2002;10(4):198\u2013207. https:\/\/doi.org\/10.1046\/J.1524-475x.2002.10402.X","journal-title":"Wound Repair Regen"},{"issue":"2","key":"7516_CR105","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/J.Jvs.2019.07.082","volume":"71","author":"RJ Brouwer","year":"2020","unstructured":"Brouwer RJ, Lalieu RC, Hoencamp R, Van Hulst RA, Ubbink DT. A systematic review and meta-analysis of hyperbaric oxygen therapy for diabetic foot ulcers with arterial insufficiency. J Vasc Surg. 2020;71(2):682\u201392. https:\/\/doi.org\/10.1016\/J.Jvs.2019.07.082","journal-title":"J Vasc Surg"},{"issue":"2","key":"7516_CR106","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S0266462308080252","volume":"24","author":"AW Chuck","year":"2008","unstructured":"Chuck AW, Hailey D, Jacobs P, Perry DC. Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. Int J Technol Assess Health Care. 2008;24(2):178\u201383. https:\/\/doi.org\/10.1017\/S0266462308080252","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"7516_CR107","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/J.Jvs.2022.05.025","volume":"76","author":"SE Browder","year":"2022","unstructured":"Browder SE, Ngeve SM, Hamrick ME, et al. Analysis of wound healing time and wound-free period in patients with chronic limb-threatening ischemia treated with and without revascularization. J Vasc Surg. 2022;76(6):1667\u201373. https:\/\/doi.org\/10.1016\/J.Jvs.2022.05.025","journal-title":"J Vasc Surg"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-023-07516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T05:04:39Z","timestamp":1698901479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-023-07516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":107,"alternative-id":["7516"],"URL":"https:\/\/doi.org\/10.1007\/s10557-023-07516-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"14 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Both Dr. Cook-Armstrong and Jayer Chung provide consent for publication and transfer of copyrights to the publisher.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}